| Select presentations below in the following formats where these icons appear: |
 RTF (opens in any word processor) PDF (slides) M.S. PowerPoint (slides)
|
Monday, May 8, 2006 |
| 8:30 am | Registration |
| 9:00-9:30 am | Welcome and Introduction |
| | Kenneth P. Moritsugu, M.D.
Deputy Surgeon General and Workshop Chair
Office of the Surgeon General | |
| | Elizabeth Nabel, M.D.
Director, National Heart, Lung, and Blood Institute | |
| | Richard Carmona, M.D., M.P.H., F.A.C.S.
Surgeon General | |
| | Thomas L. Ortel, M.D., Ph.D.
Science Co-Chair
Duke University Medical Center | |
| | Samuel Z. Goldhaber, M.D.
Science Co-Chair
Harvard Medical School | |
| | Heidi Blongastainer
DVT patient | |
| | Melanie Bloom
National DVT Patient Spokesperson | |
| | Kenneth P. Moritsugu, M.D. | |
| 9:30-10:45 am | Panel #1: Epidemiology of Deep Vein Thrombosis |
| | Epidemiology of Venous Thromboembolism
Text alternative for slides | John A. Heit, M.D.
Mayo Clinic
1.9 MB
652 KB
252 KB |
| | Modifiable and Non-Modifiable Risk Factors for Venous Thromboembolism
Text alternative for slides | Mary Cushman, M.D.
University of Vermont
88 KB
2.1 MB
324 KB |
| | Thrombosis in the Pediatric Patient: Unique Risk Factors, Diagnosis, and Management Issues
Text alternative for slides | Marilyn Manco-Johnson, M.D.
University of Colorado
44 KB
19.1 MB
476 KB |
| | Sequelae and Cost of Venous Thromboembolism
Text alternative for slides | Samuel Z. Goldhaber, M.D.
Harvard Medical School
10.3 MB
2.8 MB
352 KB |
| | Summary
| Thomas L. Ortel, M.D., Ph.D.
Duke University Medical Center |
| 10:45-11:00 am | Break |
| 11:00 am-12:00 noon | Panel #2: High-Risk Groups for Deep Vein Thrombosis |
| | Venous Thromboembolism in the Cancer Patient
Text alternative for slides | Ajay Kakkar, M.B.B.S., Ph.D.
Queen Mary University of London and Thrombosis Research Institute
16 KB
1.1 MB
156 KB |
| | Women's Issues: Pregnancy, Oral Contraceptives, and Hormone Replacement Therapy
Text alternative for slides | Suman Rathbun, M.D., M.S.
University of Oklahoma Health Sciences Center
232 KB
116 KB
540 KB |
| | General Surgery, Orthopedic Surgery, Trauma, and Immobility | Lt. Col. Donald H. Jenkins, M.D.
USAF, Chairman, General Surgery and Chief of Trauma Services, 59th Medical Wing, Wilford Hall Medical Center
152 KB
32 KB
24 KB |
| | Summary | Thomas L. Ortel, M.D., Ph.D.
Duke University Medical Center |
| 12:00-1:00 pm | Lunch |
| 1:00-2:00 pm | Panel #3: Diagnosing Deep Vein Thrombosis |
| | Diagnosis of Deep Venous Thrombosis and Pulmonary Embolism
Text alternative for slides | Jeffrey I. Weitz, M.D.
McMaster University, Hamilton, Canada
512 KB
2.6 MB
236 KB |
| | Feasibility of a National Screening Program for Venous Disease
Text alternative for slides | Robert B. McLafferty, M.D.
Southern Illinois University
36 KB
1.9 MB
120 KB |
| | Laboratory Testing and the Thrombophilia Workup
Text alternative for slides | Thomas L. Ortel, M.D., Ph.D.
Duke University Medical Center
270 KB
416 KB
160 KB |
| | Summary | Samuel Z. Goldhaber, M.D |
| 2:00-3:00 pm | Panel #4: Approaches to Treating Deep Vein Thrombosis |
| | Anticoagulant Therapies and the Treatment of Venous Thromboembolism
Text alternative for slides | Kenneth A. Bauer, M.D.
Harvard Medical School
40 KB
388 KB
116 KB |
| | Management Issues With Oral Anticoagulant Therapy
Text alternative for slides | Jack E. Ansell, M.D.
Boston University
40 KB
1.1 MB
136 KB |
| | Aggressive Intervention Strategies and the Role of Graduated Compression Stockings
Text alternative for slides | Thomas W. Wakefield, M.D
University of Michigan
104 KB
204 KB
324 KB |
| | Summary | Thomas L. Ortel, M.D., Ph.D.
Duke University Medical Center |
| 3:00-3:15 pm | BREAK |
| 3:15-4:30 pm | Panel #5: Awareness and Best Practices Regarding Deep Vein Thrombosis |
| | Awareness and Best Practices Regarding Deep Vein Thrombosis
Text alternative for slides | Franklin A. Michota, M.D
Cleveland Clinic Foundation
5.4 MB
824 KB |
| | Update on National Quality Forum Activities Related to DVT
Text alternative for slides | Lisa Hines, M.S.
National Quality Forum
168 KB
80 KB |
| | Question Session 1 | Samuel Z. Goldhaber, M.D., Moderator |
| | Personal Perspectives on Venous Thromboembolism and the Role of Patient Advocacy Groups
Text alternative for slides | Mark Jablonski
President, National Alliance for Thrombosis and Thrombophilia
32 KB
1.8 MB
68 KB |
| | Personal Perspective on Venous Thromboembolism | Michael Hefron
DVT patient
32 KB |
| | Question Session 2 | Samuel Z. Goldhaber, M.D., Moderator
Panel Members:
Heidi Blongastainer
Melanie Bloom |
| | Summary | Samuel Z. Goldhaber, M.D.
Harvard Medical School |
| 4:30-5:00 pm | Review of Day 1 With Discussion; Overview of Day 2 | Dr. Moritsugu, Dr. Goldhaber, and Dr. Ortel |
Tuesday, May 9, 2006 |
| 8:30-9:30 am | Panel #6: Prevention of Deep Vein Thrombosis |
| | Venous Thromboembolism Practice for the Medical Patient
Text alternative for slides | John A. Heit, M.D.
Mayo Clinic
112 KB
204 KB
152 KB |
| | Thrombosis Risk Assessment as a Guide to Thrombosis Prophylaxis in the Surgical Patient
Text alternative for slides | Joseph A. Caprini, M.D.
Northwestern University
40 KB
608 KB
152 KB |
| | Strategies To Improve Use of Thromboprophylaxis for Venous Thromboembolism
Text alternative for slides | Samuel Z. Goldhaber, M.D.
Harvard Medical School
796 KB
108 KB
132 KB |
| | Summary | Thomas L. Ortel, M.D., Ph.D.
Duke University Medical Center |
| 9:30-10:30 am | Panel #7: Translation and Application Issues in Relation to Deep Vein Thrombosis |
| | Translation of Evidence-Based Data Into Clinical Practice
Text alternative for slides | Joseph A. Caprini, M.D.
Northwestern University
24 KB
792 KB
228 KB |
| | Unique Needs for Women and the Pediatric Patient Population
Text alternative for slides | Andra H. James, M.D.
Duke University Medical Center
140 KB
52 KB
40 KB |
| | Strategies To Improve Use of Thromboprophylaxis for Venous Thromboembolism
Text alternative for slides | Stephan Moll, M.D.
University of North Carolina, Chapel Hill
196 KB
1.3 MB
156 KB |
| | Summary | Samuel Z. Goldhaber, M.D.
Harvard Medical School |
| 10:30-10:45 am | Break |
| 10:45 am-12:15 pm | Small-Group Discussions |
| 12:15-1:15 pm | Lunch |
| 1:15-2:45 pm | Small-Group Reports and Discussion |
| | Group A: Clinical Approaches to Enhancing Diagnosis and Treatment | |
| | Group B: Primary Prevention of VTE | |
| | Group C: Enhancing the DVT Science Base and Accelerating Clinical and Public Health Applications
| |
| | Group D: Public Health Priorities
| |
| | Group E: Enhancing Existing Collaborations and Developing New Partnerships | |
| 2:45-3:45 pm | Summary and Consideration of Priority Areas for Action
Text alternative for slides | Dr. Moritsugu, Dr. Goldhaber, and Dr. Ortel
28 KB
48 KB |
| 3:45-4:00 pm | Closing Remarks and Next Steps | Dr. Richard Carmona
U.S. Surgeon General |
Print 
Download Reader 
